Targeting FASN‐mediated de novo fatty acid synthesis can suppress the hyperactivation of RA‐FLSs; this indicates that dysregulated lipid metabolism in RA‐FLSs may play a pivotal role in the pathogenesis of RA. This evidence concerns the gene FASN and rheumatoid arthritis.